Next Generation Diagnostics System Increment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

6
FORT DETRICK, MD – The U.S. Army Medical Materiel Development Activity, in partnership with BioFire Defense LLC, announced U.S. Food and Drug Administration marketing approvals for the Next Generation Diagnostics System Increment 1 Infectious Disease Panel, also known as the Global Fever Panel, and the associated External Control Kit.
The FilmArray® Global Fever Panel is a commercially available single-use, fully enclosed test for use with the BioFire® FilmArray 2.0 instrument to aid in the diagnosis of malaria, dengue fever, chikungunya fever and leptospirosis.
Although these diseases are rare in the United States, they are common in other parts of the world where U.S. Service Members are or may be deployed. ....

United States , Biofire Filmarray , Clifford Snyder , Biofire Defense , Infectious Disease Panel , Naval Health Research Center , Department Of Defense , Us Service Members , Us Army Medical Research Directorate , Armed Forces Research Institute Of Medical Sciences , Nuclear Defense , Human Services National Institute Of Allergy , Care Project Management Office , Defense Health Agency , Global Fever Panel , Us Army Medical Research , Drug Administration , Program Executive Office For Chemical , Naval Medical Research Unit , Us Army Medical Materiel Development Activity , Infectious Disease Panel Integrated Product Team , Medical Materiel Development Activity , Next Generation Diagnostics System Increment , Disease Panel , External Control , Acute Care Project Management ,